Smoking Cessation After Intra-gastric Balloons Placement: An Interesting Side-effect for Smoker Patients: Preliminary Report

Gustavo L Carvalho, PhD, Diego L Lima, Student, Adriano C Sales, Student, Rafaela L Gouveia, Student, Rebeca G Rocha, Student, Flavio A Fernandes Junior, MD, Masaichi Okazaki, MD. University of Pernambuco – Faculty of Medical Sciences


INTRODUCTION: Obesity is a major health problem with substantial morbidity and mortality. The use of intra-gastric balloons for obesity and non-obese patients has been reported with success to weight loss. Different types of treatment for stop smoking have been created over years, but the smoking cessation in addicted patients who underwent gastric balloon placement has never been reported.

METHOD: From June 2006 to January 2011, 221 patients with pre-treatment BMI between 25.1 and 63.5 were submitted to treatment with Silimed Intra-gastric Balloons (SIB). Smoker patients were selected for evaluation of smoke intolerance during the SIB treatment. This study included 19 patients (18 women), with mean age of 40.0 years (23 to 55 years). They comprised two groups of pre-obese and obese patients who failed to respond to previous clinical treatment for weight loss. Their pretreatment mean weight was 90.1±22.5 kg (58.3 to 207 kg), mean BMI was 34.21± 5.2 kg/m2 (25.6 to 63.5 kg/m2). During their intra-gastric balloon treatment, they reported to our team an unusual smoke intolerance which was classified in three groups: tolerance or small intolerance, partial intolerance and total intolerance. Patients classified as small intolerance presented an initial intolerance but started smoking again less than 1 month after the beginning of the balloon placement or didn´t present any intolerance. Patients classified as partial intolerance stopped smoking for at least 3 months. And patients classified as total intolerance stopped smoking completely. Those patients were followed after the balloon removal regarding the continuity of smoke intolerance.

RESULTS: 3 of 19 patients (15.78%) were placed in the small intolerance group. Also 3 of 19 patients (15.78%) composed the partial intolerance group. And 13 patients (68.44%) stopped smoking completely, compounding the total intolerance group. After the balloon treatment (6 months) the patients were accompanied for both weight loss and smoking intolerance. All patients in the small tolerance group and partial intolerance group didn´t stop smoking. 6 of 13 patients (46.15%) located in the total intolerance group stop smoking and didn´t start again after the end of the balloon treatment.

CONCLUSIONS: SIB is a useful and safe treatment for obesity patients. At this moment SIB can not be proposed as a new treatment for stop smoking and proper investigation of this interesting and comon side effect still needed to be pursued.

Session Number: Poster – Poster Presentations
Program Number: P476
View Poster

« Return to SAGES 2012 abstract archive